Active · per the CBE, 18 November 2026

DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE

BE0828298539

Rechtspersoon Private limited company 1 establishment

DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is a general practice in Maldegem. Private Limited, started on 5 August 2010, 1 establishment.

Oude Staatsbaan 156, 9991 Maldegem

Behind the company: Kristoff Muylle, Marijke Reynders.

Active for

16 year, 3 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE from Maldegem, company number BE0828298539, closed financial year 2025 with a result of € 166,200 after tax. For that financial year DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE recorded a gross margin of € 356,216 and equity of € 977,009. Compared with financial year 2024, the result moved from € 192,188 to € 166,200. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2026.

What it is worth Healthy

€ 977,009

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 166,200

▼ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 113,174

▼ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 209,722 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 15,943

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 9 years to go

€ 650,241

▼ 10% vs 2024

€ 72,951 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 27,462

▲ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18,362

▼ 68% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
2022202320242025Change 2024 → 2025
Gross margin € 226,306 € 343,309 € 401,011 € 356,216 ▼ 11%
Profit after taxes € 108,932 € 178,087 € 192,188 € 166,200 ▼ 14%
Equity € 677,251 € 828,342 € 1,020,531 € 977,009 ▼ 4%
Total debts € 874,709 € 852,942 € 804,092 € 758,152 ▼ 6%
Cash € 417,230 € 313,566 € 117,329 € 113,174 ▼ 4%
Land & buildings € 757,113 € 726,524 € 938,989 € 900,824 ▼ 4%
Retained profit € 671,051 € 822,142 € 1,014,331 € 970,809 ▼ 4%
Dividend € 44,527 € 26,995 € 0 € 209,722
Bank debt € 720,089 € 643,664 € 721,965 € 650,241 ▼ 10%
Balance sheet total € 1,551,960 € 1,681,284 € 1,824,623 € 1,735,161 ▼ 5%

By gross margin, DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE ranks 2nd of 4 companies with main activity “Activiteiten van huisartspraktijken” in Maldegem that publish figures (fiscal year 2025).

Key figures of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE?

What happened at DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 166,200 (▼ 14% vs 2024). filed late Source: NBB ↗
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Maldegem. KBO

In short

From € 108,932 profit in 2022 to € 166,200 profit in 2025.

Paid € 288,308 in corporate taxes since 2022.

Best year ever: 2024, with € 192,188 profit.

Paid out € 281,244 in dividends to the owners in total.

Management

Kristoff Muylle Marijke Reynders
DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE

Behind DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE are Kristoff Muylle and Marijke Reynders.

Directors

According to the 2025 annual accounts

Kristoff Muylle

Director

Marijke Reynders

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Oude Staatsbaan 156

9991 Maldegem

2.194.332.416

Staatsbaan 156

9991 Maldegem

Active since 5 August 2010

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Maldegem

Same main activity (Activiteiten van huisartspraktijken), 3 active companies in Maldegem, largest first.

Dokter Hans De Schuyter, huisarts

€ 397,148 gross margin · 2025

JASPER LANDA - HUISARTS

€ 280,107 gross margin · 2026

Dr. KUPPENS - Dr. BRODÖHL

€ 82,159 gross margin · 2025

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • Muylle, Kristoff(vennoot) 50%
  • Reynders, Marijke(vennoot) 50%

Details

Company number
0828.298.539
VAT number
BE 0828.298.539
Registered office
Oude Staatsbaan 156, 9991 Maldegem
Names & denominations
DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
5 August 2010
Peppol
Active · Active since 11 Dec 2025
Activities · NACE

Activiteiten van huisartspraktijken

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What does DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE do?
DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is a general practice in Maldegem. Private Limited, started on 5 August 2010, 1 establishment.
What is the address of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE?
The registered office of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is located at Oude Staatsbaan 156, 9991 Maldegem.
Is DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE still active?
Yes. According to the CBE (18 November 2026) DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is active, legal situation “Normale toestand”, started on 5 August 2010.
Is DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE registered on Peppol?
Yes, DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is registered on the Peppol network with ID 0208:0828298539.
What is the enterprise number of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE?
The enterprise number of DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE is BE0828298539.
When was DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE founded?
DR MUYLLE-NUCLEAIRE GENEESKUNDE & DR REYNDERS -KLINISCHE BIOLOGIE was founded on 5 August 2010.